SCIENTIFIC PROGRAMME

The 73rd QUADRUPLE SYMPOSIUM-2022

Surabaya (VIRTUAL), 12-13, 19-20, and 26 February 2022

1. SURABAYA DIABETES UPDATE (SDU)

2. SURABAYA OBESITY UPDATE (SOBU)
3. SURABAYA METABOLIC SYNDROME UPDATE (SUMETSU)
4. METABOLIC CARDIOVASCULAR DISEASE SURABAYA UPDATE (MECARSU)

Theme:
Recent Advances in the Pathogenesis and Treatment
of Diabetes and Its Complications
(Going beyond the Glucose up to 2025)

Host:
PERKENI Surabaya Branch and PAPDI Surabaya Branch

Secretariat
Surabaya Diabetes and Nutrition Center (SDNC)
Jl. Mayjen Prof. Moestopo 6-8 Surabaya
Telp. (031) 5023866 Fax. (031) 5012775
e-mail : perkenicabsurabaya@yahoo.com
Kata Pengantar
Ketua Umum The 73rd Quadruple Joint Symposium – 2022

Sejawat yang kami hormati,

Diabetes adalah masalah kesehatan utama yang telah mencapai
tingkat yang mengkhawatirkan. Menurut IDF 2021 hari ini, lebih dari
setengah miliar orang dan Indonesia menduduki peringkat 5 besar Negara
dengan penderita diabetes 2021 – 2045.
Diabetes Melitus (DM) merupakan salah satu PTM yang banyak menyita
perhatian masyarakat dan pemerintah. Selain karena jumlahnya yang setiap
tahunnya mengalami peningkatan, DM juga masuk kedalam 10 penyakit yang
menyumbangkan angka kecacatan dan kematian tertinggi akibat komplikasi baik akut
maupun kronis di Indonesia.
Sehingga sangatlah penting bagi para klinisi untuk memahami hubungan
hubungan prediktif antara risiko metabolik, DM dan komplikasinya, serta mampu
melakukan intervensi agresif untuk mencegah atau memperlambat progresivitas
komplikasi baik akut maupun kronis.
Untuk itulah PERKENI cabang Surabaya bekerja sama dengan PAPDI cabang
Surabaya bersama para pakar dari 13 Pusat Diabetes di Indonesia akan membahas
diabetes, terapi nutrisi medis, mencari solusi dan berusaha merumuskan informasi
ilmiah terkini untuk pencegahan komplikasi akut dan kronis. Acara ini akan diisi dengan
plenary lecture 14 guru besar, pembicara dan moderator simposium dari seluruh
Indonesia yang mencakup kota dari Banda Aceh, Medan, Padang, Palembang, Jakarta,
Bandung, Jogjakarta, Solo, Semarang, Surabaya, Malang, Denpasar, Makassar dan
Manado. Acara ini kami kemas dalam bentuk:
THE 73rd QUADRUPLE JOINT SYMPOSIUM – 2022 yang mengandung 4 kegiatan
1. SURABAYA METABOLIC SYNDROME UPDATE (SUMETSU)
2. METABOLIC CARDIOVASCULAR DISEASE SURABAYA UPDATE (MECARSU)
3. SURABAYA OBESITY UPDATE (SOBU)
4. SURABAYA DIABETES UPDATE (SDU)
TEMA : Recent Advances in the Pathogenesis and Treatment of Diabetes and Its Complications
(Going beyond the Glucose up to 2025)
Kami mengucapkan terima kasih atas partisipasi aktif dari Sejawat sekalian
demi suksesnya acara yang penting ini dan kami berharap acara ilmiah ini akan
memberi manfaat yang besar pada pengelolaan diabetes dan komplikasinya.

Ketua Umum Panitia

Hermawan Susanto, dr., Sp.PD, K-EMD, FINASIM

THE 73rd QUADRUPLE JOINT SYMPOSIUM – 2022
PELINDUNG
Prof. Dr. Budi Santoso, dr., Sp.OG (K)
(Dekan FK. Universitas Airlangga)

Dr. Joni Wahyuhadi, dr, Sp.BS(K)

(Direktur Utama RSUD Dr. Soetomo)

PENASEHAT
Prof. Purnomo Suryohudoyo, dr, SpBK

PENGARAH
Prof. Dr. Askandar Tjokroprawiro, dr., Sp.PD, K-EMD, FINASIM
Prof. Dr. Ari Sutjahjo, dr., Sp.PD, K-EMD, FINASIM
Prof. Dr. Agung Pranoto, dr., M.Kes, Sp.PD, K-EMD, FINASIM

KETUA UMUM
Hermawan Susanto, dr, Sp.PD, K-EMD, FINASIM

SEKRETARIS
Jongky Hendro Prajitno, dr., Sp.PD, K-EMD, FINASIM

BENDAHARA
Sri Murtiwi, dr., Sp.PD, K-EMD, FINASIM

SEKSI ACARA ILMIAH

Prof. Dr. Askandar Tjokroprawiro, dr., Sp.PD, K-EMD, FINASIM
Prof. Dr. Agung Pranoto, dr., M.Kes, Sp.PD, K-EMD, FINASIM
Sri Murtiwi, dr., Sp.PD, K-EMD, FINASIM
Dr. Soebagijo Adi Soelistijo, dr., Sp.PD, K-EMD, FINASIM, FACP
Dr. Sony Wibisono Mudjanarko, dr., Sp.PD, K-EMD, FINASIM
Dr. Hermina Novida, dr., Sp.PD, K-EMD, FINASIM

SEKSI ACARA / PROTOKOL

Panji Mulyono, dr., Sp.PD, K-EMD, FINASIM
Ganjar Adityo Permadi, dr., Sp.PD
Karin Dhia Fahmita, dr
Faizal Armando Nugroho, dr
Dewi Prasetyaningtyas, dr

SEKSI PERLENGKAPAN
Rio Wironegoro, dr., Sp.PD, FINASIM
Zaki Nugraha Kumara Putra, dr., Sp.PD
Radhitya Farizky Deta Juniawan, dr
Satyawardana, dr

SEKSI KONSUMSI
Deasy Ardiany, dr., Sp.PD, K-EMD, FINASIM
Rizky Amalia Putri, dr

SEKSI PUBLIKASI DAN DOKUMENTASI

Dr. Libriansyah, dr., MM, Sp.PD, K-EMD, FINASIM, AIFO-K
Gunar Isya Firdauzi, dr

SEKSI AUDIO VISUAL

Rosyid Narendra, dr., Sp.PD
Dwiki Novendrianto, dr
Muhammad Andi Putra N., dr
Aditya Dias Pradana, dr

SEKSI REGISTRASI
Bayu Aji Hariowardoyo, dr
Saturday, 12 February 2022
07.00 – 08.20 : Registration

08.00 – 08.10 : Chairman of the Symposium The 73rd QUADRUPLE SYMPOSIUM-2021

Hermawan Susanto, dr., Sp.PD, K-EMD, FINASIM

08.10 – 08.30 : Chairman of Indonesian Medical Association Surabaya Branch

Dr. Brahmana Askandar Tjokroprawiro, dr., Sp.OG (K)
Code of Ethics for Medical Advertising

08.30 – 08.55 : Opening Programme

Surabaya Diabetes and Nutrition Centre (SDNC) at a Glance: Past, Present, and Future
Dr. Soebagijo Adi Soelistijo, dr., Sp.PD, K-EMD, FINASIM, FACP

08.55 – 10.10 : PLENARY LECTURE-1

Chairman : Prof. Syafril Syahbuddin, dr., Sp.PD, K-EMD, FINASIM
08.55 – 09.20 : Drs. Andi Widjaja, PhD, DABCC, MBA
The Possible Therapy of the Three of Egregious Eleven of Pts with DM
(Immune Dysregulation, Abnormal Colonic Microbiome, and Low Amylin in
Small Intestine)
09.20 – 09.45 : Prof. Slamet Suyono, dr., Sp.PD, K-EMD, FINASIM
Ketogenic Diet: Is it Suitable Metabolically and Clinically for Diabetic Patients?
09.45 – 10.10 : Prof. Dr. Askandar Tjokroprawiro, dr., Sp.PD, K-EMD, FINASIM
The Use of Resveratrol for Diabetes Mellitus, Cardiovascular Event and
Selective Metabolic Diseases as Observed in Clinical Practice

10.15 – 11.10 : SYMPOSIUM PRELUNCH-1

Diabetes & Hypertension: from Guidelines to Clinical Practice
Chairmen : - Prof. Dr. Askandar Tjokroprawiro, dr., Sp.PD, K-EMD, FINASIM
- Alwi Shahab, dr., Sp.PD, K-EMD, FINASIM
10.15 – 10.35 : Dr. Sony Wibisono Mudjanarko, dr., Sp.PD, K-EMD, FINASIM
Diabetes & Ramadan Practical Guidelines
(Focus on Local Data DIA RAMADAN)
10.35 – 10.55 : Jongky Hendro Prajitno, dr., Sp.PD, K-EMD, FINASIM
Translating Guidelines into Practice
(Evidence from Perindopril based SPCs for Diabetic Patients with Hypertension)
10.55 – 11.10 : Discussion

11.10 – 12.05 : SYMPOSIUM LUNCH-1

Delivering Tailored Care for the Broad Condition of T2DM Patients in Indonesia
Chairman : Prof. Dr. A.A.G. Budhiarta, dr., Sp.PD, K-EMD, FINASIM
11.10 – 11.30 : Hermawan Susanto, dr., Sp.PD, K-EMD, FINASIM
Early Aggressive Therapy for T2DM Patients: What's Next Post Metformin?
11.30 – 11.50 : Prof. Dr. Agung Pranoto, dr., M.Kes., Sp.PD, K-EMD, FINASIM
The Paradox of Choice in Type 2 Diabetes: The Simultaneous Benefit of Insulin
and DPP4i
11.50 – 12.05 : Discussion
Sunday, 13 February 2022
09.00 – 09.50 : PLENARY LECTURE-2
Chairman : Prof. H.A.H Asdie dr., Sp.PD, K-EMD, FINASIM
09.00 – 09.25 : Prof. Harsinen Sanusi dr, Sp.PD, K-EMD, FINASIM
Evolution Treatment of Diabetes Mellitus
09.25 – 09.50 : Prof. Dr. Johan S Masjhur, dr., Sp.PD, K-EMD, Sp.KN, FINASIM
Thyro-Diabetes

09.55 – 10.50 : SYMPOSIUM PRELUNCH -2

Chairman : Prof. Dr. Pradana Soewondo, dr., Sp.PD, K-EMD, FINASIM
09.55 – 10.15 : Dr. Soebagijo Adi Soelistijo, dr., Sp.PD, K-EMD, FINASIM, FACP
Personalazing T2DM Treatment to Reduce Cardio Renal Risk
10.15 – 10.35 : Dr. Tjokorda Gde Dalem Pemayun, dr., Sp.PD, K-EMD, FINASIM
Personalazing T2DM treatment to reduce cardio renal risk: Deepdive into clinical
practice discussion
10.35 – 10.50 : Discussion

10.50 – 11.45 : SYMPOSIUM LUNCH-2

Chairmen : - Prof. Dr. Askandar Tjokroprawiro, dr., Sp.PD, K-EMD, FINASIM
- Krishna W. Sucipto, dr., SpPD, K-EMD, FINASIM
10.50 – 11.10 : Sri Murtiwi, dr., Sp.PD, K-EMD, FINASIM
Dulaglutide an Once Weekly GLP1-RA: Significant Efficacy, Simply Achieved for
T2D Treatment
11.10 – 11.30 : Prof. Dr. Agung Pranoto, dr., M.Kes, Sp.PD, K-EMD, FINASIM
Dulaglutide is the First and only T2D Medicine Approved to Reduce CV Events
in Adults with and without Established CVD
11.30 – 11.45 : Discussion
Saturday, 19 February 2022
09.00 – 10.15 : PLENARY LECTURE-3
Chairman : Prof. Dr. Dharma Lindarto, dr., Sp.PD, K-EMD, FINASIM
09.00 – 09.25 : Prof. Dr. Asman Manaf, dr., Sp.PD, K-EMD, FINASIM
Early Insulinization for Better Glucose Control in Management of T2DM
09.25 – 09.50 : Prof. Dr. Karel Pandelaki, dr., Sp.PD, K-EMD, FINASIM
Crosstalk between Pancreatic Cells on Glucose Homeostasis
09.50 – 10.15 : Prof. Dr. Sidartawan Soegondo, dr., Sp.PD, K-EMD, DTM&H, FINASIM, FACE
The Possible Treatment of Brain Dysfunction Involved in the Egregious Eleven
(Increased Appetite, Decreased Morning Dopamine Surge, and Increased
Sympathetic Tone)

10.20 – 11.15 : SYMPOSIUM PRELUNCH-3

Management of T2DM
Chairman : Prof. Dr. Imam Subekti, dr., Sp.PD, K-EMD, FINASIM
10.20 – 10.40 : Dr. K. Heri Nugroho H.S., dr., Sp.PD, K-EMD, FINASIM
Inlacin: Insulin resistance & Updated Clinical Study
10.40 – 11.00 : Dr. Soebagijo Adi Soelistijo, dr., Sp.PD, K-EMD, FINASIM, FACP
Optimizing Glycemic Control with Fixed Dose Combination
(Focus on FDC Glimepiride + Metformin)
11.00 – 11.15 : Discussion

11.15 – 12.10 : SYMPOSIUM LUNCH-3

Building on Foundations: Helping to Optimize Care for People with Diabetes
Chairperson : Sri Murtiwi, dr., Sp.PD, K-EMD, FINASIM
11.15 – 11.35 : Deasy Ardiany, dr., Sp.PD, K-EMD, FINASIM
Climbing beyond HbA1c: The Importance of Managing Hypoglycemia
11.35 – 11.55 : Dr. Hermina Novida, dr., Sp.PD, K-EMD, FINASIM
Leveraging Time-in-Range to Improve Patient Outcomes
11.55 – 12.10 : Discussion
Sunday, 20 February 2022
09.00 – 10.15 : PLENARY LECTURE-4
Chairman : Prof. Dr. Sarwono Waspadji, dr., Sp.PD, K-EMD, FINASIM
09.00 – 09.25 : Prof. Dr. Achmad Rudijanto, dr., Sp.PD, K-EMD, FINASIM
What do We Know about Beta-Cell Heterogeneity?
09.25 – 09.50 : Prof. Dr. Darmono, dr., Sp.PD, K-EMD, FINASIM
Diabetes Mellitus in the Elderly
(Challenge in Co-morbidity and Multi Organ Dysfunctions)
09.50 – 10.15 : Prof. Dr. Djanggan Sargowo, dr., Sp.PD, Sp.JP(K), FIHA, FACC, FESC,
FCAPC, FASCC
The Role of Trimetazidine for Improving Cardiac Metabolism in Ischemic Heart
Disease: When and How to Start

10.20 – 11.25 : SYMPOSIUM PRELUNCH-4

Chairmen : - Prof. Dr. Askandar Tjokroprawiro, dr., Sp.PD, K-EMD, FINASIM
- Dr. Santi Syafril, dr., Sp.PD, K-EMD, FINASIM
10.20 – 10.40 : Prof. Dr. A. Makbul M. Aman, dr, Sp.PD, K-EMD, FINASIM
The New Once-Weekly Semaglutide Targets Unmet Needs in T2DM
10.40 – 11.00 : Dr. Libriansyah, dr., MM, Sp.PD, K-EMD, FINASIM, AIFO-K
Semaglutide: Superior A1C Reduction, Weight Loss and CV Risk Reduction with
Once-Weekly Convenience
11.00 – 11.15 : Discussion

11.15 – 12.10 : SYMPOSIUM LUNCH-4

Obesity – Diabetes – Thyroid
Chairman : R. Bowo Pramono, dr., Sp.PD, K-EMD, FINASIM
11.15 – 11.35 : Sri Murtiwi, dr., Sp.PD, K-EMD, FINASIM
Effect of Orlistat in Overweight and Obese Patients with Type 2 DM
11.35 – 11.55 : Dr. Sony Wibisono Mudjanarko, dr., Sp.PD, K-EMD, FINASIM
Diagnosis and Management of Hyperthyroidsm: A Rational Approach
11.55 – 12.10 : Discussion
Saturday, 26 February 2022
08.30 – 09.45 : PLENARY LECTURE-5
Chairman : Prof. John MF Adam, dr., Sp.PD, K-EMD, FINASIM
08.30 – 08.55 : Prof. Dr. Ketut Suastika, dr., Sp.PD, K-EMD, FINASIM
Overcoming Treatment Inertia of Prediabetes
08.55 – 09.20 : Prof. Djoko Santoso, dr., Ph.D., Sp.PD., K-GH., FINASIM
Diabetic Kidney Disease: Focus on its Pathophysiology and Classification
(Nephrologist’s View)
09.20 – 09.45 : Prof. Dr. Agung Pranoto, dr., M.Kes., Sp.PD, K-EMD, FINASIM
Diabetic Kidney Disease: Focus on its Management
(Diabetologist’s View)

09.45 – 10.40 : SYMPOSIUM PRELUNCH-5

The Evolving Strategy of T2D Management : SGLT2i insights
Chairmen : - Prof. Dr. Askandar Tjokroprawiro, dr., Sp.PD, K-EMD, FINASIM
- Rio Wironegoro, dr., Sp.PD, K-EMD, FINASIM
09.45 – 10.05 : Prof. Dr. Eva Decroli, dr., Sp.PD, K-EMD, FINASIM
Shifting Paradigm in T2D Management
(New Insights into Empagliflozin Cardiorenal Metabolic Benefit)
10.05 – 10.25 : Dr. Hermina Novida, dr., Sp.PD, K-EMD, FINASIM
Achieving Early Glucose Control
(Powerful HbA1c Reduction by FDC Empagliflozin/Linagliptin)
10.25 – 10.40 : Discussion

10.40 – 11.35 : SYMPOSIUM LUNCH-5

Managing Hidden Faces of Diabetes to Prevent Cardiovascular
Complication
Chairmen : - Prof. Dr. Askandar Tjokroprawiro, dr., Sp.PD, K-EMD, FINASIM
- Supriyanto Kartodarsono, dr., Sp.PD, K-EMD, FINASIM
10.40 – 11.00 : Dr. Sony Wibisono Mudjanarko, dr., Sp.PD, K-EMD, FINASIM
Ensuring Optimal Statin Management of DM Patient
11.00 – 11.20 : Dr. Hikmat Permana, dr., Sp.PD, K-EMD, FINASIM
Revealing Statin Benefit in Diabetic Kidney Disease Patients
11.20 – 11.35 : Discussion
11.35 – 12.05 : Break

12.05 – 13.30 : SYMPOSIUM POSTLUNCH

Effective and Convenient Alternative in T2D Management: Simplification
with Fixed Ratio Combination
Chairman : - Prof. Dr. Askandar Tjokroprawiro, dr., Sp.PD, K-EMD, FINASIM
- Putu Moda Arsana, dr., Sp.PD, K-EMD, FINASIM
12.05 – 12.25 : Sri Murtiwi, dr., Sp.PD, K-EMD, FINASIM
Simultaneous Approach to Improve the Management of Adult T2DM with
Uncontrolled with OAD and Basal Insulin: New Evidence from SOLIMIX
12.25 – 12.45 : Hendra Zufry, dr., Sp.PD, K-EMD, FINASIM
Rationale Use of Fix Ratio Combination Basal Insulin GLP1RA
12.45 – 13.00 : Discussion
 BIAYA PENDAFTARAN SYMPOSIUM
 Dokter Umum Rp. 150.000
 IPD Rp. 500.000
 Spesialis Lain Rp. 750.000

ALUR REGISTRASI :
1. Kunjungi website https://bit.ly/qsympo
2. Lakukan pembayaran sesuai profesi masing-masing
dengan menambahkan nama peserta di keterangan/ Berita
Sekretariat Panitia sebelum tgl 11 Februari 2022
dan transfer ke:
Bank Jatim Cab. RSUD Dr. Soetomo Surabaya
Panitia https://bit.ly/qsympo
Surabaya Diabetes Update
No. Rek. : 0321005454
3. Isi form dan upload bukti pembayaran, kemudian klik kirim.
https://bit.ly/qsympo
4. Mohon menunggu untuk proses verifikasi oleh panitia.
5. Konfirmasi pembayaran akan dikirimkan melalui email yang
didaftarkan.
6. Link webinar akan dikirimkan melalui email H-3 sampai H-1
sebelum acara dimulai.
7. Jika batal tidak ada pengembalian uang.

CP: Bayu Aji Hariowardoyo, dr (0813 8822 9799)

Secretariat
Surabaya Diabetes and Nutrition Center (SDNC)
Jl. Mayjen Prof. Moestopo 6-8 Surabaya
Telp. (031) 5023866 Fax. (031) 5012775
e-mail : perkenicabsurabaya@yahoo.com